Sectors & IndustriesHealthcareHealthcare Plans

Best Healthcare Plan Stocks to Buy Now (2025)

Top healthcare plan stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best healthcare plan stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:

Cvs Health (NYSE:CVS) is the #1 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Cvs Health (NYSE:CVS) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: A.

Cvs Health (NYSE:CVS) has a Due Diligence Score of 36, which is -1 points lower than the healthcare plan industry average of 37. Although this number is below the industry average, our proven quant model rates CVS as a "B".

CVS passed 12 out of 38 due diligence checks and has average fundamentals. Cvs Health has seen its stock return 19.18% over the past year, overperforming other healthcare plan stocks by 57 percentage points.

Cvs Health has an average 1 year price target of $78.18, an upside of 18.64% from Cvs Health's current stock price of $65.90.

Cvs Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Cvs Health, 63.64% have issued a Strong Buy rating, 18.18% have issued a Buy, 18.18% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Alignment Healthcare (NASDAQ:ALHC) is the #2 top healthcare plan stock out of 11 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Alignment Healthcare (NASDAQ:ALHC) is: Value: D, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: C, and AI: B.

Alignment Healthcare (NASDAQ:ALHC) has a Due Diligence Score of 35, which is -2 points lower than the healthcare plan industry average of 37.

ALHC passed 12 out of 33 due diligence checks and has average fundamentals. Alignment Healthcare has seen its stock return 70.93% over the past year, overperforming other healthcare plan stocks by 109 percentage points.

Alignment Healthcare has an average 1 year price target of $18.56, an upside of 25.77% from Alignment Healthcare's current stock price of $14.76.

Alignment Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Alignment Healthcare, 50% have issued a Strong Buy rating, 12.5% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Elevance Health (NYSE:ELV) is the #3 top healthcare plan stock out of 11 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Elevance Health (NYSE:ELV) is: Value: A, Growth: C, Momentum: D, Sentiment: D, Safety: C, Financials: C, and AI: B.

Elevance Health (NYSE:ELV) has a Due Diligence Score of 54, which is 17 points higher than the healthcare plan industry average of 37.

ELV passed 19 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -45.21% over the past year, underperforming other healthcare plan stocks by -7 percentage points.

Elevance Health has an average 1 year price target of $400.15, an upside of 35.91% from Elevance Health's current stock price of $294.43.

Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Elevance Health, 69.23% have issued a Strong Buy rating, 15.38% have issued a Buy, 15.38% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 4 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 3.13%, which is 1 percentage points higher than the healthcare plan industry average of 1.97%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 36.6% indicates that its dividend yield is sustainable for the long-term.

Elevance Health (NYSE:ELV) has an annual dividend yield of 2.27%, which is the same as the healthcare plan industry average of 1.97%. Elevance Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Elevance Health's dividend has shown consistent growth over the last 10 years.

Elevance Health's dividend payout ratio of 28.3% indicates that its dividend yield is sustainable for the long-term.

Cvs Health (NYSE:CVS) has an annual dividend yield of 2.02%, which is the same as the healthcare plan industry average of 1.97%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 36.9% indicates that its dividend yield is sustainable for the long-term.

Healthcare plan stocks were up 2.23% in the last day, and up 7.66% over the last week.

We couldn't find a catalyst for why healthcare plan stocks are up.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare plan stocks right now are:

Elevance Health (NYSE:ELV) is the most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Elevance Health has a valuation score of 57, which is 35 points higher than the healthcare plan industry average of 22. It passed 4 out of 7 valuation due diligence checks.

Elevance Health's stock has dropped -45.21% in the past year. It has underperformed other stocks in the healthcare plan industry by -7 percentage points.

Molina Healthcare (NYSE:MOH) is the second most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Molina Healthcare has a valuation score of 29, which is 7 points higher than the healthcare plan industry average of 22. It passed 2 out of 7 valuation due diligence checks.

Molina Healthcare's stock has dropped -52.94% in the past year. It has underperformed other stocks in the healthcare plan industry by -15 percentage points.

Cigna Group (NYSE:CI) is the third most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cigna Group has a valuation score of 29, which is 7 points higher than the healthcare plan industry average of 22. It passed 2 out of 7 valuation due diligence checks.

Cigna Group's stock has dropped -13.3% in the past year. It has overperformed other stocks in the healthcare plan industry by 25 percentage points.

40% of healthcare plan stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare plan stocks to rise by 25.79% over the next year.

0% of healthcare plan stocks have a Zen Rating of A (Strong Buy), 10% of healthcare plan stocks are rated B (Buy), 80% are rated C (Hold), 10% are rated D (Sell), and 0% are rated F (Strong Sell).